Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra A Hoppensteadt

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 5, 2003
Generic forms of low-molecular-weight heparins: some practical considerationsWendy Leong, Debra A Hoppensteadt
Seminars in Thrombosis and Hemostasis|January 5, 2005
Monitoring the new antithrombotic drugsJeanine M Walenga, Debra A Hoppensteadt
Hematology/Oncology Clinics of North America|January 22, 2008
The relationship between the antiphospholipid syndrome and heparin-induced thrombocytopeniaDebra A Hoppensteadt, Jeanine M Walenga
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 19, 2003
Management of thrombotic and cardiovascular disorders in the new milleniumJawed Fareed, Debra A Hoppensteadt, Rodger L Bick
Seminars in Thrombosis and Hemostasis|April 16, 2004
Epilogue. Expanded role of low-molecular-weight heparins in hematology and oncologyDebra A Hoppensteadt, Jawed Fareed, Rodger L Bick
Seminars in Respiratory and Critical Care Medicine|February 28, 2008
The future of anticoagulationDebra A Hoppensteadt, Walter Jeske, Jeanine Walenga, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 16, 2010
Contaminants in heparins: are all facts known?Jawed Fareed, Debra A Hoppensteadt, Eduardo Ramacciotti, et al.
Seminars in Thrombosis and Hemostasis|April 16, 2004
Laboratory analysis of blood samples from patients treated with tinzaparinDebra A Hoppensteadt, Louise Willows, Helen Leitz, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 14, 2006
Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfateJyothi Maddineni, Debra A Hoppensteadt, Umberto Cornelli, et al.
Future Cardiology|October 7, 2009
Update on the clinical applications of argatrobanJawed Fareed, Walter P Jeske, Debra A Hoppensteadt, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 5, 2003
Generic forms of low-molecular-weight heparins: some practical considerationsWendy Leong, Debra A Hoppensteadt
Seminars in Thrombosis and Hemostasis|January 5, 2005
Monitoring the new antithrombotic drugsJeanine M Walenga, Debra A Hoppensteadt
Hematology/Oncology Clinics of North America|January 22, 2008
The relationship between the antiphospholipid syndrome and heparin-induced thrombocytopeniaDebra A Hoppensteadt, Jeanine M Walenga
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 19, 2003
Management of thrombotic and cardiovascular disorders in the new milleniumJawed Fareed, Debra A Hoppensteadt, Rodger L Bick
Seminars in Thrombosis and Hemostasis|April 16, 2004
Epilogue. Expanded role of low-molecular-weight heparins in hematology and oncologyDebra A Hoppensteadt, Jawed Fareed, Rodger L Bick
Seminars in Respiratory and Critical Care Medicine|February 28, 2008
The future of anticoagulationDebra A Hoppensteadt, Walter Jeske, Jeanine Walenga, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 16, 2010
Contaminants in heparins: are all facts known?Jawed Fareed, Debra A Hoppensteadt, Eduardo Ramacciotti, et al.
Seminars in Thrombosis and Hemostasis|April 16, 2004
Laboratory analysis of blood samples from patients treated with tinzaparinDebra A Hoppensteadt, Louise Willows, Helen Leitz, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 14, 2006
Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfateJyothi Maddineni, Debra A Hoppensteadt, Umberto Cornelli, et al.
Future Cardiology|October 7, 2009
Update on the clinical applications of argatrobanJawed Fareed, Walter P Jeske, Debra A Hoppensteadt, et al.
Pageof 5